---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-037365"
form_type: "8-K/A"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:29:00.256678+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical closes SPAC merger with $84.2M in financing; reports H1 2024 net loss of $14.5M

## Summary
- Business combination with ARYA Sciences Acquisition Corp IV closed on July 31, 2024, providing ~$84.2 million in financing.
- Transaction costs corrected to ~$13.1 million, including $1M payoff of SVB Term Loan.
- Adagio Medical's H1 2024 revenue $280,000; net loss $14.5 million; cash $2.0 million as of June 30, 2024.
- Working capital deficit of $58.0 million at June 30, 2024; going concern doubt alleviated by merger closing.
- Adagio issued $15.5 million in convertible notes during H1 2024; converted 207,902 preferred shares for pre-funded warrants.

## SEC filing metadata
- accession: 0001140361-24-037365
- form_type: 8-K/A
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000114036124037365/0001140361-24-037365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000114036124037365/ef20034052_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-037365
- JSON: https://secwatch.observer/filing/0001140361-24-037365.json
- Plain text: https://secwatch.observer/filing/0001140361-24-037365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.